Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    The Potential Hidden Costs of Combination Products - Lachman Blog

    The Potential Hidden Costs of Combination Products

    With the development of new technologies and drugs, the need for certa...
    Read More
    Prevention is Better than Cure - Lachman Blog

    Prevention is Better than Cure!

    I think we would all agree that the above saying very much applies to ...
    Read More
    Curiouser and Curiouser! Late-Cycle Amendments under GDUFA III Part 2 - Lachman Blog 2

    Curiouser and Curiouser! Late-Cycle Amendments under GDUFA III Part 2

    The last blog that we drafted on this topic, The Curious Case of the L...
    Read More
    A Peek at the June 2024 Mid-Month ANDA Approval Actions - Lachman Blog

    A Peek at the June 2024 Mid-Month ANDA Approval Actions

    After two stellar months, the OGD approvals (at least through mid-June...
    Read More
    Suitability Petition Metrics - Lachman Blog

    Suitability Petition Metrics

    Any frequent reader of the Lachman blog is well acquainted with the bl...
    Read More
    FDA Finalizes New Final Guidance on Facility Readiness and Goal Dates - Lachman Blog

    FDA Finalizes New Final Guidance on Facility Readiness and Goal Dates

    The FDA received no comments on the draft guidance titled Facility Rea...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today